PT - JOURNAL ARTICLE AU - Ebru Oral AU - Keith K Wannomae AU - Dmitry Gil AU - Rachel Connolly AU - Joseph A Gardecki AU - Hui Min Leung AU - Orhun K Muratoglu AU - Amy Tsurumi AU - Laurence Rahme AU - Tareq Jaber AU - Cassidy Collins AU - Julian Gjore AU - Amanda Budzilowicz TI - Efficacy of moist heat decontamination against various pathogens for the reuse of N95 respirators in the COVID-19 emergency AID - 10.1101/2020.05.13.20100651 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.13.20100651 4099 - http://medrxiv.org/content/early/2020/06/26/2020.05.13.20100651.short 4100 - http://medrxiv.org/content/early/2020/06/26/2020.05.13.20100651.full AB - Decontamination of N95 respirators has become critical to alleviate PPE shortages for healthcare workers in the current COVID-19 emergency. The factors that are considered for the effective reuse of these masks are the fit, filter efficiency and decontamination/disinfection level both for SARS-CoV2, which is the causative virus for COVID-19, and for other organisms of concern in the hospital environment such as Staphylococcus aureus or Clostridium difficile.The efficacy of inactivation or eradication against various pathogens should be evaluated thoroughly to understand the level of afforded disinfection. Methods commonly used in the sterilization of medical devices such as ionizing radiation, vaporized hydrogen peroxide, and ethylene oxide can provide a high level of disinfection, defined as a 6 log10 reduction, against bacterial spores, considered the most resistant microorganisms. CDC guidance on the decontamination and reuse of N95s also includes the use of moist heat (60°C, 80% relative humidity, 15-30 min) as a possible recommendation based on literature showing preservation of fit efficiency and inactivation of H1N1 on spiked masks.Here, we explored the efficacy of using moist heat under these conditions as a decontamination method for an N95 respirator (3M 1860S, St. Paul, MN) against various pathogens with different resistance; enveloped RNA viruses, Gram (+/-) bacteria, and non-enveloped viruses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no external funding for the work. The authors and their institutions each self-funded their portions of the work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is an in vitro study and did not involve any human or animal subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data obtained is largely presented in the manuscript. Any other details which may not be directly presented may be requested form the authors.